Novabay Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Novabay Pharmaceuticals shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Novabay Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Novabay Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Novabay Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $23k | 221k | 0.11 |
2023-12-31 | $1.7k | 8.5k | 0.20 |
2023-09-30 | $112 | 249 | 0.45 |
2023-03-31 | $308 | 182 | 1.70 |
2022-12-31 | $9.6k | 4.9k | 1.95 |
Top funds holding Novabay Pharmaceuticals
View all funds holding Novabay Pharmaceuticals